Price T Rowe Associates Inc Bridge Bio Pharma, Inc. Transaction History

Price T Rowe Associates Inc

$812 Billion
Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,164,967 shares of BBIO stock, worth $57.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,164,967

Previous 991,238 17.53%

Holding current value

$57.2 Million

Previous $27.2 Million 48.07%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$28.12 - $37.59 $4.89 Million - $6.53 Million	173,729 Added 17.53%	1,164,967 $40.3 Million
Q4 2024 Feb 14, 2025	BUY	$22.35 - $29.5 $4.04 Million - $5.33 Million	180,773 Added 22.3%	991,238 $27.2 Million
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $343,180 - $449,248	-14,353 Reduced 1.74%	810,465 $20.6 Million
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $479,826 - $647,556	20,862 Added 2.59%	824,818 $20.9 Million
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $3.98 Million - $5.89 Million	145,594 Added 22.11%	803,956 $24.9 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $14.3 Million - $26.2 Million	596,386 Added 962.29%	658,362 $26.6 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $37,495 - $77,722	2,220 Added 3.72%	61,976 $1.64 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $60,535 - $82,035	4,555 Added 8.25%	59,756 $1.03 Million
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $81,171 - $210,004	-11,321 Reduced 17.02%	55,201 $916,000
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $112,989 - $193,121	-16,764 Reduced 20.13%	66,522 $507,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $54,873 - $85,419	-6,911 Reduced 7.66%	83,286 $828,000
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $124,899 - $291,032	23,973 Added 36.2%	90,197 $819,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $177,906 - $415,924	24,238 Added 57.73%	66,224 $672,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $28,529 - $133,898	-2,507 Reduced 5.63%	41,986 $700,000
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $23.4 Million - $32 Million	-498,672 Reduced 91.81%	44,493 $2.09 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $2.92 Million - $4.02 Million	-62,825 Reduced 10.37%	543,165 $33.1 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $31.9 Million - $41.7 Million	575,776 Added 1905.66%	605,990 $37.3 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $1.16 Million - $2.15 Million	30,214 New	30,214 $2.15 Million

Others Institutions Holding BBIO

# of Institutions

392

Shares Held

187M

Call Options Held

12.7M

Put Options Held

2.28M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $7.28B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Bridge Bio Pharma, Inc. Transaction History